Citations

Clear

3942 citation(s) found for "To, Van".

Liver transplant‐free survival according to alkaline phosphatase and GLOBE score in patients with primary biliary cholangitis treated with ursodeoxycholic acid
Veer, Rozanne C. de , Harms, Maren H. , Thorburn, Douglas , Janssen, Harry L.A. , Nevens, Frederik , Lindor, Keith D. , Floreani, Annarosa , Ponsioen, Cyriel Y. , Mayo, Marlyn J. , Parés, Albert , Mason, Andrew L. , Bruns, Tony , Buuren, Henk R. van , Meer, Adriaan J. van der, Group, the Global PBC Study, van der Meer, Adriaan J , Invernizzi, Pietro , Lindor, K D , Mayo, Marlyn J , Mason, Andrew , Hirschfield, Gideon M , Bruns, Tony , Verhelst, Xavier , Corpechot, Christophe , Invernizzi, Pietro , Battezzati, Pier Maria , Kowdley, Kris V. , Trivedi, Palak Jitendrakumar , Hirschfield, Gideon M. , Dalekos, George Ν. , Gatselis, Nikolaos , Verhelst, Xavier , Lammers, Willem J. , Hansen, Bettina E. , Meer, Adriaan J. van der, Group, the Global PBC Study

Mayo Clinic

Alimentary Pharmacology & Therapeutics | September 23, 2022 | Volume: 56 | Issue: 9 | Pages: 1408-1418

10.1111/apt.17226 | PMID 36138566 Get It

SummaryBackgroundAfter 1 year of ursodeoxycholic acid (UDCA), patients with primary biliary cholangitis (PBC) may have a normal GLOBE score despite high alkaline phosphatase (ALP) levels.AimTo assess the association between ALP and liver transplantation (LT)‐free survival according to the GLOBE scoreMethodsAmong patients with a normal or elevated GLOBE score in the Global PBC cohort, the association between ALP after 1 year of UDCA and the risk of LT/death was assessed. The LT‐free survival was compared with that of a matched general population.ResultsAfter 1 year of UDCA, ALP was associated with the risk of LT/death (aHR 1.31, 95% CI 1.003–1.72, p = 0.048) among 2729 patients with a normal GLOBE score. The 10‐year LT‐free survival among these patients with an ALP >2.0 × ULN was 94.0% (95% CI 90.1–97.9) for those <50 years, and 82.6% (95% CI 76.5–88.7) for those ≥50 years, which was significantly lower (p = 0.040) and similar (p = 0.736) to that of the matched population, respectively. The 10‐year LT‐free survival in patients ≥50 years with normal GLOBE score and normal ALP (90.8%, 95% CI 87.7–93.9) was significantly higher (p = 0.022) than the matched population. Among 1045 patients with an elevated GLOBE score, ALP was associated with LT/death only in those <50 years (aHR 1.38, 95% CI 1.06–1.81, p = 0.016).ConclusionThe LT‐free survival of patients with PBC with a normal GLOBE score is optimal in case of normal ALP levels, also in relation to the general population. Despite their generally favourable prognosis, an elevated ALP level may still indicate a need for add‐on therapy.
Low postoperative lymphocyte count increases risk of progression in human papillomavirus associated oropharyngeal cancer
Routman, David M. , Day, Courtney N. , Harmsen, William S. , Haller, Travis J. , Moore, Eric J. , Foote, Robert L. , Neben-Wittich, M.A. , Price, Katharine A. , Abel, Kathryn M. Van , Haller, Travis, Moore, Eric J , Neben-Wittich, Michelle, Van Abel, Kathryn M , Routman, David M , Yin, Linda X. , Bartemes, Kathleen R. , Price, Daniel L. , Chintakuntlawar, Ashish V. , Daniel, J.

Mayo Clinic

Head & Neck | September 21, 2022 | Volume: 44 | Issue: 12 | Pages: 2760-2768

10.1002/hed.27198 | PMID 36129387 Get It

AbstractBackgroundWe aim to explore the prognostic role of absolute lymphocyte count (ALC) before, during, and after treatment on oncologic outcomes in human papillomavirus associated oropharyngeal cancer (HPV(+)OPSCC).MethodsRetrospective cohort at a tertiary center, 2006–2018. Multivariable Cox regressions were used to determine the effect of ALC on risk of progression. Univariate linear regression was performed to determine clinical factors associated with lower ALC.ResultsAll 197 patients underwent primary surgery. Mean (SD) ALC nadirs (×109 cells/L) were: baseline (N = 149): 1.69 (0.56); postoperative (N = 126): 1.58 (0.59); post‐RT (N = 141): 0.68 (0.35) and long‐term (N = 105): 0.88 (0.37). Lower baseline ALC nadir was associated with worse overall survival (HR 3.85, 95%CI: 1.03–14.29, p = 0.04). Lower postoperative ALC nadir was associated with higher risk of progression (HR 2.63, 95%CI: 1.04–6.67, p = 0.04).ConclusionsLower baseline ALC is associated with worse survival, whereas lower postoperative ALC is associated with increased risk of progression in surgically treated HPV(+)OPSCC.Level of Evidence3
Transfer learning identifies in vivo senescence heterogeneity and contributions to vascularization and matrix production across species and diverse pathologies
Stivers, Katlin B. , Gray-Gaillard, Elise , Ruta, Anna , Hamada, Naomi, Hamada, Masakazu , Trewartha, Shawn , Wolf, Matthew, Keerthivasan, Shilpa , Saux, Claude Le, Housseau, Franck , Deursen, Jan M. van , Pardoll, Drew, Elisseeff, Jennifer H. , Cherry, Christopher, Andorko, James I. , Krishnan, Kavita , Mejías, Joscelyn C. , Nguyen, Helen Hieu , Han, Jin , Hamada, Naomi, Hamada, Masakazu, Sturmlechner, Ines , Michel, John H. , Huyer, Locke Davenport , Tam, Ada J , Peña, Alexis N. , Fertig, Elana Judith , Baker, Darren J.

Mayo Clinic

No container title available | September 20, 2022 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-1847932/v1 Get It

Abstract Cellular senescence is a state of permanent growth arrest that plays an important role in wound healing, tissue fibrosis, and tumor suppression. Despite senescent cells’ (SnC) pathological role and therapeutic interest, their phenotype in vivo remains poorly defined. Here, we developed an in vivoderived senescence signature using a foreign body response (FBR) fibrosis model in a SnC reporter mouse. We identified pericytes and “cartilage-like” fibroblasts as senescent and defined cell typespecific senescence associated secretory phenotypes (SASP). Transfer learning and senescence scoring identified these two SnC populations along with endothelial and epithelial SnCs in new and publicly available murine and human data single cell RNAseq (scRNAseq) datasets from diverse pathologies. Signaling analysis uncovered crosstalk between SnCs and myeloid cells via an IL34- CSF1R-TGFßR signaling axis, contributing to tissue balance of vascularization and matrix production. Overall, our study provides a senescence signature and a computational approach that may be broadly applied to identify transcriptional profiles and SASP factors produced by SnCs that regulate tissue structure and pathology.
P18 Pemigatinib for previously treated locally advanced or metastatic cholangiocarcinoma: final results from FIGHT-202
Sahai, Vaibhav , Vaccaro, Gina M. , Rajabi, Raed MAl, Paulson, Andrew Scott , Gallinson, David, Oh, Do‐Youn , Catenacci, Daniel V.T. , Lihou, Christine , Véronèse, L., Sahai, Vaibhav , Vogel, Arndt , Hollebecque, Antoine , Melisi, Davide , Borad, Mitesh J. , Murphy, Adrian , Dotan, Efrat , Cutsem, Eric Van , Zhen, Huiling, Abou‐Alfa, Ghassan K.

Mayo Clinic

Abstracts | September 20, 2022 | Volume: No volume available | Issue: No issue available | Pages: A44.1-A44

10.1136/gutjnl-2022-basl.69 Get It

P09 Long-term obeticholic acid (OCA) for Primary Biliary Cholangitis (PBC) in a clinical trial improved event free survival (death, liver transplant and hepatic decompensation) compared to external controls from the GLOBAL PBC real-world database
Perez, Carla , Adekunle, Femi, Mayne, Tracy J. , Malecha, Elizabeth Smoot, Ness, Eric , Meer, Adriaan J Van Der, Nevens, Frederik , Bruns, Tony , Floreani, Annarosa , Mayo, Marlyn J. , Thorburn, Douglas , Gulamhusein, Aliya , Bowlus, Christopher L. , Lindor, Keith D. , Bruns, Tony , Bowlus, Christopher L , Meer, Adriaan van der , Lammers, Willem J. , Trivedi, Palak Jitendrakumar , Battezzati, Pier Maria , Kowdley, Kris V. , Cazzagon, Nora , Mason, Andrew L. , Parés, Albert , Londoño, Maria, Invernizzi, Pietro , Carbone, Marco , Lleò, Ana , Dalekos, George Ν. , Gatselis, Nikolaos , Verhelst, Xavier , Janssen, Harry L.A. , Trauner, Michael , Corpechot, Christophe , Hirschfield, Gideon M. , Hansen, Bettina E.

Mayo Clinic

Abstracts | September 20, 2022 | Volume: No volume available | Issue: No issue available | Pages: A37-A37

10.1136/gutjnl-2022-basl.60 Get It

MRI data-driven clustering reveals different subtypes of Dementia with Lewy bodies
Inguanzo, Anna , Przybelski, Scott A. , Diaz‐Galvan, Patricia , Lowe, Val J. , Boeve, Bradley F. , Beek, Marleen van de , Blanc‬, ‪Frederic, Sousa, Paulo Loureiro de , Philippi, Nathalie , Demuynck, Catherine, Nedelská, Zuzana , Oppedal, Ketil , Westman, Eric , Boeve, Brad , Nedelska, Zuzana , Westman, Eric , Inguanzo, Anna , Diaz-Galvan, Patricia , Ferreira, Daniel , Poulakis, Konstantinos , Mohanty, Rosaleena , Schwarz, Christopher G. , Lemstra, Afina W. , Flier, Wiesje M. van der , Barkhof, Frederik , Cretin, Benjamin , Hort, Jakub , Segura, Bàrbara , Junqué, Carme , Aarsland, Dag , Kantarci, Kejal

Mayo Clinic

No container title available | September 19, 2022 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-2015284/v1 Get It

Abstract Background. Dementia with Lewy bodies (DLB) is a neurodegenerative disorder with a wide heterogeneity of symptoms, which suggests the existence of different subtypes. Objectives. We used data-driven analysis of MRI data to investigate DLB subtypes. Methods. We included 165 probable DLB from the Mayo Clinic and 3 centers from the European DLB consortium and performed a hierarchical cluster analysis to identify subtypes based on gray matter (GM) volumes. To characterize the subtypes, we used demographic and clinical data, as well as β-amyloid and cerebrovascular biomarkers at baseline, and cognitive decline over three years. Results. We identified 3 subtypes: an older subtype with reduced cortical GM volumes, worse cognition, and faster cognitive decline (n=49, 30%); a subtype with low GM volumes in fronto-occipital regions (n=76, 46%); and a subtype of younger patients with the highest cortical GM volumes, proportionally lower GM volumes in basal ganglia and the highest frequency of cognitive fluctuations (n=40, 24%). Conclusions. This study shows the existence of MRI subtypes in DLB, which may have implications for clinical workout, research, and therapeutic decisions.
Open and Endoscopic Endonasal Biopsies for Langerhans Cell Histiocytosis of the Hypothalamus: 2-Dimensional Operative Video
Bauman, Megan M. J. , Janus, Jeffrey R. , Gompel, Jamie J. Van , Van Gompel, Jamie J , Bauman, Megan

Mayo Clinic

Operative Neurosurgery | September 16, 2022 | Volume: 23 | Issue: 5 | Pages: e328-e328

10.1227/ons.0000000000000386 | PMID 36113147 Get It

Poly(ADP-ribose) promotes toxicity of C9ORF72 arginine-rich dipeptide repeat proteins
Gao, Junli , Mewborne, Quinlan T. , Girdhar, Amandeep , Sheth, Udit , Coyne, Alyssa N. , Punathil, Ritika , Kang, Bong Gu , Dasovich, Morgan , Veire, Austin M. , Hernandez, Mariely DeJesus, Liu, Shuaichen , Shi, Zheng , Dafinca, Ruxandra , Talbot, Kevin , Zhang, Yong‐Jie , Petrucelli, Leonard , Blitterswijk, Marka van , Guo, Lin , Dawson, Ted M. , Veire, Austin , DeJesus Hernandez, Mariely, Fouquerel, Elise , Talbot, Kevin , Kam, Tae-In , Zhang, Yong-Jie , Dickson, Dennis W , Petrucelli, Leonard , van Blitterswijk, Marka , Guo, Lin , Dawson, Ted M , Dawson, Valina L , Leung, Anthony K L , Lloyd, Thomas E , Gendron, Tania F , Rothstein, Jeffrey D , Zhang, Ke , Coyne, Alyssa N , Sheth, Udit , Liu, Shuaichen, Kam, Tae‐In , Dickson, Dennis W. , Dawson, Valina L. , Gendron, Tania F. , Rothstein, Jeffrey D. , Zhang, Ke

Mayo Clinic

Science Translational Medicine | September 14, 2022 | Volume: 14 | Issue: 662 | Pages: No page available

10.1126/scitranslmed.abq3215 | PMID 36103513 Get It

Arginine-rich dipeptide repeat proteins (R-DPRs), abnormal translational products of a GGGGCC hexanucleotide repeat expansion in C9ORF72 , play a critical role in C9ORF72 -related amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD), the most common genetic form of the disorders (c9ALS/FTD). R-DPRs form liquid condensates in vitro, induce stress granule formation in cultured cells, aggregate, and sometimes coaggregate with TDP-43 in postmortem tissue from patients with c9ALS/FTD. However, how these processes are regulated is unclear. Here, we show that loss of poly(ADP-ribose) (PAR) suppresses neurodegeneration in c9ALS/FTD fly models and neurons differentiated from patient-derived induced pluripotent stem cells. Mechanistically, PAR induces R-DPR condensation and promotes R-DPR–induced stress granule formation and TDP-43 aggregation. Moreover, PAR associates with insoluble R-DPR and TDP-43 in postmortem tissue from patients. These findings identified PAR as a promoter of R-DPR toxicity and thus a potential target for treating c9ALS/FTD.
Combined Middle Fossa and Transmastoid Approach for Resection of Petrous Temporal Meningioma With Facial Nerve Reanimation by Interposition Grafting: 2-Dimensional Operative Video
Rinaldo, Lorenzo , Nassiri, Ashley M. , Neff, Brian A., Flanigan, Patrick M, Flanigan, Patrick Michael , Gompel, Jamie J. Van

Mayo Clinic

Operative Neurosurgery | September 14, 2022 | Volume: 23 | Issue: 4 | Pages: e293-e293

10.1227/ons.0000000000000349 | PMID 36103350 Get It

Higher Cell-Mediated Immune Responses in Patients With Inflammatory Bowel Disease on Anti-TNF Therapy After COVID-19 Vaccination
Caldera, Freddy , Necela, Brian M. , Cogen, Davitte , Saha, Sumona , Wald, Arnold , Daoud, Nader , Chun, Kelly , Grimes, Ian, Lutz, Megan , Helden, Sean R Van, Swift, Melanie D. , Virk, Abinash , Bharucha, Adil E. , Chumsri, Saranya , Knutson, Keith L. , Saha, Sumona , Swift, Melanie D , Caldera, Freddy , Farraye, Francis A. , Helden, Sean R. Van , Patel, Tushar , Gores, Gregory J. , Hayney, Mary S. , Knutson, Keith L.

Mayo Clinic

Inflammatory Bowel Diseases | September 14, 2022 | Volume: 29 | Issue: 8 | Pages: 1202-1209

10.1093/ibd/izac193 | PMID 36103273 Get It

Abstract Background Some patients with inflammatory bowel disease (IBD) on immunosuppressive therapies may have a blunted response to certain vaccines, including the messenger RNA (mRNA) coronavirus disease 2019 (COVID-19) vaccines. However, few studies have evaluated the cell-mediated immune response (CMIR), which is critical to host defense after COVID-19 infection. The aim of this study was to evaluate the humoral immune response and CMIR after mRNA COVID-19 vaccination in patients with IBD. Methods This prospective study (HERCULES [HumoRal and CellULar initial and Sustained immunogenicity in patients with IBD] study) evaluated humoral immune response and CMIR after completion of 2 doses of mRNA COVID-19 vaccines in 158 IBD patients and 20 healthy control (HC) subjects. The primary outcome was the CMIR to mRNA COVID-19 vaccines in patients with IBD. The secondary outcomes were a comparison of (1) the CMIR in patients with IBD and HC subjects, (2) CMIR and humoral immune response in all participants, and (3) correlation between CMIR and humoral immune response. Results The majority (89%) of patients with IBD developed a CMIR, which was not different vs HC subjects (94%) (P = .6667). There was no significant difference (P = .5488) in CMIR between immunocompetent (median 255 [interquartile range, 146-958] spike T cells per million peripheral blood mononuclear cells) and immunosuppressed patients (median 377 [interquartile range, 123-1440]). There was no correlation between humoral and cell-mediated immunity after vaccination (P = .5215). In univariable analysis, anti-tumor necrosis factor therapy was associated with a higher CMIRs (P = .02) and confirmed in a multivariable model (P = .02). No other variables were associated with CMIR. Conclusions Most patients with IBD achieved CMIR to a COVID-19 vaccine. Future studies are needed evaluating sustained CMIR and clinical outcomes.